Tessa Speidel

机构：Moderna Therapeutics (United States)

发表论文 10 篇 · 总被引 258 次 · h-index 7

代表论文

• SARS-CoV-2 viral clearance and evolution varies by type and severity of immunodeficiency (2024 · Science Translational Medicine · 被引 100)
• Safety and antiviral effect of a triple combination of HIV-1 broadly neutralizing antibodies: a phase 1/2a trial (2024 · Nature Medicine · 被引 62)
• Viral evolution prediction identifies broadly neutralizing antibodies to existing and prospective SARS-CoV-2 variants (2025 · Nature Microbiology · 被引 40)
• mRNA-1273 vaccines adapted to JN.1 or KP.2 elicit cross-neutralizing responses against the JN.1 sublineages of SARS-CoV-2 in mice (2025 · Vaccine · 被引 15)
• Viral evolution prediction identifies broadly neutralizing antibodies against existing and prospective SARS-CoV-2 variants (2024 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 15)
• SARS-CoV-2 Viral Clearance and Evolution Varies by Extent of Immunodeficiency (2023 · medRxiv · 被引 11)